These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 4945665
21. Virus-induced antigens - a review. Klein G. IARC Sci Publ (1971); 1975; (11 Pt 1):293-308. PubMed ID: 190131 [No Abstract] [Full Text] [Related]
22. Localization of complement-fixing antigens in cells: Epstein-Barr virus-induced membrane and interior cell antigens. Hollinshead A, Lee O, Alford TC. J Gen Virol; 1971 Dec; 13(3):441-7. PubMed ID: 4334299 [No Abstract] [Full Text] [Related]
23. Some factors affecting membrane immunofluorescence reactivity of Burkitt lymphoma tissue culture cell lines. Yata J, Klein G. Int J Cancer; 1969 Nov 15; 4(6):767-75. PubMed ID: 4907973 [No Abstract] [Full Text] [Related]
24. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Henle W, Henle G, Zajac BA, Pearson G, Waubke R, Scriba M. Science; 1970 Jul 10; 169(3941):188-90. PubMed ID: 4316788 [Abstract] [Full Text] [Related]
31. The EB virus. Epstein MA, Achong BG. Annu Rev Microbiol; 1973 Jan 30; 27():413-36. PubMed ID: 4356531 [No Abstract] [Full Text] [Related]
32. Comparison of the anti-EBV titer and the EBV-associated membrane reactive and precipitating antibody levels in the sera of Burkitt lymphoma and nasopharyngeal carcinoma patients and controls. Klein G, Geering G, Old LJ, Henle G, Henle W, Clifford P. Int J Cancer; 1970 Mar 15; 5(2):185-94. PubMed ID: 4915449 [No Abstract] [Full Text] [Related]
33. Cellular immunity: immune responses and the herpes-like virus. Glade PR, Hirschhorn K. Cell Immunol; 1970 Oct 15; 1(4):359-61. PubMed ID: 4331868 [No Abstract] [Full Text] [Related]
34. Relation between Epstein-- Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. II. Comparison of cells and sera from patients with Burkitt's lymphoma and infectious mononucleosis. Klein G, Pearson G, Henle G, Henle W, Diehl V, Niederman JC. J Exp Med; 1968 Nov 01; 128(5):1021-30. PubMed ID: 4878907 [Abstract] [Full Text] [Related]
35. Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma. Klein G. Isr J Med Sci; 1977 Jul 01; 13(7):716-24. PubMed ID: 200586 [No Abstract] [Full Text] [Related]
36. Epstein-Barr virus infections. Middleton PJ. Can Med Assoc J; 1974 Jan 05; 110(1):9-10. PubMed ID: 4358535 [No Abstract] [Full Text] [Related]
37. Antibodies to herpes-type virus in nasopharyngeal carcinoma and control groups. Lin TM, Yang CS, Ho SW, Chiou JF, Liu CH, Tu SM, Chen KP, Ito YH, Kawamura A, Hirayama T. Cancer; 1972 Mar 05; 29(3):603-9. PubMed ID: 4334237 [No Abstract] [Full Text] [Related]
38. Host responses to herpesviruses - a review. Henle W, Henle G. IARC Sci Publ (1971); 1975 Mar 05; (11 Pt 2):215-24. PubMed ID: 191365 [No Abstract] [Full Text] [Related]
39. Direct membrane fluorescence reaction of EBV-carrying human lymphoblastoid cells: blocking tests with xenogeneic antisera. Bremberg S, Klein G, Epstein A. Int J Cancer; 1969 Nov 15; 4(6):761-6. PubMed ID: 4907972 [No Abstract] [Full Text] [Related]
40. Reactivity of radioiodinated serum antibody from Burkitt's lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Bukrkitt's lymphoma. Inoue M, Klein G. Clin Exp Immunol; 1970 Jul 15; 7(1):39-50. PubMed ID: 4320551 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]